InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Veillon-Berteloot Chantal. Director active across 1 company, notably Integra Lifesciences Holdings CORP. In total, 7 disclosures have been published. Activity tracked since 1 September 2023. The latest transaction was disclosed on 1 September 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Veillon-Berteloot Chantal is linked to Integra Lifesciences Holdings CORP, where she is EVP & CHRO. She has 6 filings in total, and in the 6 sampled filings from 2023-09-05 to 2026-03-12, the reported amounts are all tax withholding, with sum_buy_eur at 0 and sum_sell_eur at 0.